NeuBase Therapeutics Appoints Todd P. Branning Chief Financial Officer
DRUGGING THE GENOMETM WITH PRECISION GENETIC MEDICINE
Many diseases remain undruggable with current therapeutic modalities. Nearly all diseases are driven by genetic mutations. NeuBase is advancing first-in-class precision genetic medicines to “drug the genome” and address disease at its base level to help millions of patients, who currently have no therapeutic options.